{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:34:45Z","timestamp":1791228885152,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Foundation of 2018 Beijing Key Clinical Specialty Construction Project\u2013Pediatrics","award":["2199000726"],"award-info":[{"award-number":["2199000726"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.clml.2020.09.009","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T19:19:16Z","timestamp":1603567156000},"page":"e137-e144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1\u2013Positive Pediatric Acute Lymphoblastic Leukemia in China"],"prefix":"10.1016","volume":"21","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Juan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Dong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xi","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2020.09.009_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/08880018.2014.983625","article-title":"Clinical features and prognostic significance of TCF3-PBX1 fusion gene in Chinese children with acute lymphoblastic leukemia by using a modified ALL-BFM-95 protocol","volume":"32","author":"Pang","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.clml.2020.09.009_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26557","article-title":"Pediatric acute lymphoblastic leukemia with t(1;19)\/TCF3-PBX1 in Taiwan","volume":"64","author":"Yen","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.09.009_bib3","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.09.009_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V87.4.1211.bloodjournal8741211","article-title":"Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis","volume":"87","author":"Hunger","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.09.009_bib5","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/leu.2009.42","article-title":"Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)\/TCF3-PBX1","volume":"23","author":"Jeha","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.09.009_bib6","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.2147\/OTT.S115257","article-title":"E2A-PBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol","volume":"9","author":"Hu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clml.2020.09.009_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3324\/haematol.11239","article-title":"Incidence and outcome of TCF3-PBX1\u2013positive acute lymphoblastic leukemia in Austrian children","volume":"92","author":"Kager","year":"2007","journal-title":"Haematologic"},{"key":"10.1016\/j.clml.2020.09.009_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199808273390907","article-title":"Acute lymphoblastic leukemia","volume":"339","author":"Pui","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.09.009_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00277-018-3338-1","article-title":"The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Hong","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.09.009_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00277-011-1285-1","article-title":"Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Zhao","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2020.09.009_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/bjh.16226","volume":"188","author":"Xue","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2020.09.009_bib12","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.2016.71.4774","article-title":"Impact of initial CSF findings on outcome among patients with national cancer institute standard- and high-risk B-cell acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"35","author":"Winick","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.09.009_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/ajh.25124","article-title":"Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: the first nation-wide prospective multicenter study in China","volume":"93","author":"Cui","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.09.009_bib14","doi-asserted-by":"crossref","first-page":"e27346","DOI":"10.1002\/pbc.27346","article-title":"Excellent outcome of acute lymphoblastic leukaemia with TCF3-PBX1 rearrangement in Hong Kong","volume":"65","author":"Lin","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2020.09.009_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/cam4.221","article-title":"Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children\u2019s Cancer and Leukemia Study Group (CCLSG)","volume":"3","author":"Asai","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.clml.2020.09.009_bib16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ajh.23307","article-title":"Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients","volume":"87","author":"Gao","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2020.09.009_bib17","doi-asserted-by":"crossref","first-page":"e87602","DOI":"10.1371\/journal.pone.0087602","article-title":"Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein","volume":"9","author":"Diakos","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2020.09.009_bib18","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2020.09.009_bib19","first-page":"363","article-title":"Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia","volume":"6","author":"Secker-Walker","year":"1992","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2020.09.009_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1998.16.2.527","article-title":"Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children\u2019s Cancer Group","volume":"16","author":"Uckun","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2020.09.009_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","article-title":"Prognostic impact of t(1;19)\/TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-M\u00fcnster\u2013based protocols","volume":"52","author":"Felice","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2020.09.009_bib22","doi-asserted-by":"crossref","first-page":"e170580","DOI":"10.1001\/jamaoncol.2017.0580","article-title":"Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis","volume":"3","author":"Berry","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2020.09.009_bib23","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1182\/blood-2016-12-725804","article-title":"Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia","volume":"129","author":"Campana","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2020.09.009_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.24629","article-title":"Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission","volume":"92","author":"Pemmaraju","year":"2017","journal-title":"Am J Hematol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265020305474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:21Z","timestamp":1761870921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265020305474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2152265020305474"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2020.09.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Results of the Risk-Stratified Treatment of TCF3-PBX1\u2013Positive Pediatric Acute Lymphoblastic Leukemia in China","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2020.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}